Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: A longitudinal MRI study

Experimental Neurology

Volumn 231, Issue 1, 2011, Pages 30-37

  Marcuzzo, Stefania ^a   Zucca, Ileana ^a   Mastropietro, Alfonso ^a,b   de Rosbo, Nicole Kerlero ^a   Cavalcante, Paola ^a   Tartari, Silvia ^a   Bonanno, Silvia ^a   Preite, Lorenzo ^a   Mantegazza, Renato ^a   Bernasconi, Pia ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b POLITECNICO DI MILANO   (Italy)

Author keywords

7 Tesla MRI; Amyotrophic lateral sclerosis; G93A SOD1 mice; Motor neuron disease; Muscle atrophy; Neuronal degeneration

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DISEASE COURSE; HINDLIMB; HISTOPATHOLOGY; LONGITUDINAL STUDY; MALE; MOTONEURON; MOTONEURON NUCLEUS; MOTOR CORTEX; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; NERVE CELL DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL;

ALANINE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; GLYCINE; HINDLIMB; HUMANS; LONGITUDINAL STUDIES; MALE; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MOTOR NEURONS; MUSCLE, SKELETAL; MUSCULAR ATROPHY, SPINAL; RETROGRADE DEGENERATION;

EID: 79961031180     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.05.007     Document Type: Article

References (25)

1. Achilli F., Boyle S., Kieran D., Chia R., Hafezparast M., Martin J.E., Schiavo G., Greensmith L., Bickmore W., Fisher E.M. The SOD1 transgene in the G93A mouse model of amyotrophic lateral sclerosis lies on distal mouse chromosome 12. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2005, 6:111-114.
2. Alexander G.M., Erwin K.L., Byers N., Deitch J.S., Augelli B.J., Blankenhorn E.P., Heiman-Patterson T.D. Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS. Brain Res. Mol. Brain Res. 2004, 130:7-15.
3. Andjus P.R., Bataveljí D., Vanhoutte G., Mitrecic D., Pizzolante F., Djogo N., Nicaise C., Gankam Kengne F., Gangitano C., Michetti F., van der Linden A., Pochet R., Bací G. In vivo morphological changes in animal models of amyotrophic lateral sclerosis and Alzheimer's-like disease: MRI approach. Anat. Rec. (Hoboken) 2009, 292:1882-1892.
4. Barber S.C., Shaw P.J. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic. Biol. Med. 2010, 48:629-641.
5. Brooks K.J., Hill M.D., Hockings P.D., Reid D.G. MRI detects early hindlimb muscle atrophy in Gly93Ala superoxide dismutase-1 (G93A SOD1) transgenic mice, an animal model of familial amyotrophic lateral sclerosis. NMR Biomed. 2004, 17:28-32.
6. Bucher S., Braunstein K.E., Niessen H.G., Kaulisch T., Neumaier M., Boeckers T.M., Stiller D., Ludolph A.C. Vacuolization correlates with spin-spin relaxation time in motor brainstem nuclei and behavioural tests in the transgenic G93A-SOD1 mouse model of ALS. Eur. J. Neurosci. 2007, 26:95-101.
7. Charil A., Corbo M., Filippi M., Kesavadas C., Agosta F., Munerati E., Gambini A., Comi G., Scotti G., Falini A. Structural and metabolic changes in the brain of patients with upper motor neuron disorders: a multiparametric MRI study. Amyotroph. Lateral Scler. 2009, 10:269-279.
8. Chiu A.Y., Zhai P., Dal Canto M.C., Peters T.M., Kwon Y.W., Prattis S.M., Gurney M.E. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 1995, 6:349-362.
9. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2001, 2:806-819.
10. Dobrowolny G., Aucello M., Rizzuto E., Beccafico S., Mammucari C., Boncompagni S., Bonconpagni S., Belia S., Wannenes F., Nicoletti C., Del Prete Z., Rosenthal N., Molinaro M., Protasi F., Fanò G., Sandri M., Musarò A. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008, 8:425-436.
11. Dupuis L., Echaniz-Laguna A. Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments. Curr. Drug Targets 2010, 11:1250-1261.
12. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 2004, 185:232-240.
13. Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 2000, 20:2534-2542.
14. Holzbaur E.L.F., Howland D.S., Weber N., Wallace K., She Y., Kwak S., Tchistiakova L.A., Murphy E., Hinson J., Karim R., Tan Y.X., Kelley P., McGill C.K., Williams G., Hobbs C., Doherty P., Zaleska M.M., Pangalos M.N., Walsh F.S. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol. Dis. 2006, 23:697-707.
15. Kennel P.F., Finiels F., Revah F., Mallet J. Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study. Neuroreport 1996, 7:1427-1431.
16. Lobsiger C.S., Boillée S., Cleveland D.W. Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:7319-7326.
17. Miller T.M., Kim S.H., Yamanaka K., Hester M., Umapathi P., Arnson H., Rizo L., Mendell J.R., Gage F.H., Cleveland D.W., Kaspar B.K. Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19546-19551.
18. G93A transgenic ALS mice. J. Neurosci. 2011, 31:4166-4177.
19. Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 364:362.
20. Tankersley C.G., Haenggeli C., Rothstein J.D. Respiratory impairment in a mouse model of amyotrophic lateral sclerosis. J. Appl. Physiol. 2007, 102:926-932.
21. Tu P.H., Raju P., Robinson K.A., Gurney M.E., Trojanowski J.Q., Lee V.M. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:3155-3160.
22. Weydt P., Hong S.Y., Kliot M., Möller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 2003, 14:1051-1054.
23. Wong M., Martin L.J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 2010, 19:2284-2302.
24. Zang D.W., Yang Q., Wang H.X., Egan G., Lopes E.C., Cheema S.S. Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2004, 20:1745-1751.
25. Zhang J., Zhang G., Morrison B., Mori S., Sheikh K.A. Magnetic resonance imaging of mouse skeletal muscle to measure denervation atrophy. Exp. Neurol. 2008, 212:448-457.